Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.410
-0.120 (-4.74%)
At close: Apr 2, 2026, 4:00 PM EDT
2.400
-0.010 (-0.41%)
After-hours: Apr 2, 2026, 7:19 PM EDT
Alector Market Cap
Alector has a market cap or net worth of $265.97 million as of April 2, 2026. Its market cap has increased by 101.83% in one year.
Market Cap
265.97M
Enterprise Value
46.18M
1-Year Change
101.83%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $265.97M, a decrease of -78.39%. That is a compound annual growth rate of -19.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 265.97M | 56.20% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 276.37M |
| C4 Therapeutics | 275.17M |
| Abeona Therapeutics | 274.98M |
| AC Immune | 273.80M |
| SAB Biotherapeutics | 272.67M |
| Editas Medicine | 261.32M |
| Cellectis | 260.21M |
| Sol-Gel Technologies | 259.75M |